The symptoms of inflammation, i.e. sarcopenia and cachexia, that accompany many cancers may be related to higher IL-6 levels in serum, and they are presently being investigated relative to treatment efficacy also in mCRC [34]. This evidence concerns the gene IL6 and Cachexia.